Intellia Therapeutics (NTLA) FCF Margin (QoQ) (2015 - 2026)
Intellia Therapeutics (NTLA) FCF Margin (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Intellia Therapeutics | 1.32 Bn | 1.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47,825.00 |
| Dec 31, 2025 | 26,368.00 |
| Sep 30, 2025 | 13,353.00 |
| Jun 30, 2025 | 19,743.00 |
| Mar 31, 2025 | -23,287.00 |
| Dec 31, 2024 | 26,499.00 |
| Sep 30, 2024 | -11,891.00 |
| Jun 30, 2024 | -38,374.00 |
| Mar 31, 2024 | -470,914.00 |
| Dec 31, 2023 | 516,499.00 |
| Sep 30, 2023 | -18,320.00 |
| Jun 30, 2023 | 19,690.00 |
| Mar 31, 2023 | -23,722.00 |
| Dec 31, 2022 | -7,791.00 |
| Sep 30, 2022 | 2,660.00 |
| Jun 30, 2022 | 13,559.00 |
| Mar 31, 2022 | -29,481.00 |
| Dec 31, 2021 | 51,810.00 |
| Sep 30, 2021 | -8,878.00 |
| Jun 30, 2021 | -5,015.00 |